Immune Dysfunction in Allergic Asthma

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of New Mexico
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Omalizumab

Criteria

Inclusion Criteria:

Mild asthma, adults -

Exclusion Criteria:

children. on inhaled or systemic steroids

-